hepcv
major
caus
nanb
pt
hepat
also
implic
caus
larg
proport
sporad
case
nanbh
chronic
infect
hepcv
also
link
develop
hepatocellular
carcinoma
chimpanze
marmoset
anim
found
experiment
infect
viru
propag
cell
cultur
system
hepcv
envelop
viru
diamet
positivestrand
rna
genom
genom
organ
resembl
flavivirus
pestivirus
yuntransl
segment
nucleotid
preced
continu
orf
nucleotid
follow
nucleotid
long
segment
work
requir
resolv
question
whether
genom
rna
possess
u
poti
tail
genom
also
carri
intern
poli
segment
toward
orf
genom
rna
probabl
translat
singl
polyprotein
amino
acid
process
function
protein
viral
protein
identifi
basi
predict
amino
acid
sequenc
hydrophob
plot
locat
potenti
glycosyl
site
similar
properti
pestiand
flavivirus
follow
genom
organ
predict
predict
viral
structur
protein
nucleocapsid
protein
two
envelop
glycoprotein
locat
aminotermin
end
polyprotein
follow
highli
hydrophob
protein
protein
exhibit
proteinas
helicas
replicas
domain
thu
probabl
involv
rna
replic
protein
process
replicas
domain
locat
close
carboxi
terminu
polyprotein
although
overal
nucleotid
amino
acid
homolog
hepcv
pestivirus
low
number
similar
exist
point
closer
ancestr
relationship
latter
flavivirus
first
yuntransl
segment
hepcv
genom
resembl
pestiviru
genom
size
presenc
sever
short
orf
contain
sever
segment
high
nucleotid
homolog
second
two
put
envelop
glycoprotein
hepcv
resembl
two
three
put
envelop
glycoprotein
pestivirus
genom
organ
predict
virion
structur
close
resembl
flavivirus
pestivirus
hepcv
propos
place
famili
flavivirida
suggest
classifi
new
third
genu
famili
remot
relat
pestivirus
flavivirus
nucleotid
sequenc
genom
amino
acid
sequenc
predict
viral
protein
basi
genom
sequenc
inform
immunoprob
devis
screen
blood
suppli
donor
antihepcv
antibodi
nonstructur
protein
hepcv
immunoassay
exhibit
high
effici
detect
infect
donor
though
one
caveat
antibodi
test
antigen
develop
infect
individu
month
post
infect
hand
viral
rna
detect
plasma
revers
transcript
amplif
cdna
pcr
within
day
post
infect
thu
latter
techniqu
may
becom
import
detect
hepcv
blood
tissu
techniqu
becom
wide
establish
diagnost
tool
untransl
found
highli
conserv
genom
differ
hepcv
isol
variou
part
world
replicas
domain
also
highli
conserv
consider
amino
acid
nucleotid
differ
exist
segment
long
orf
variou
hepcv
isol
diverg
among
differ
isol
particularli
great
segment
encod
two
put
envelop
glycoprotein
upstream
hydrophob
protein
variabl
envelop
glycoprotein
need
consid
develop
immunoprob
vaccin
hepcv
hepat
c
viru
hepcv
new
pestiflavilik
viru
discov
rel
recent
main
caus
non
non
b
hepat
nanbh
abbrev
hepcv
suggest
hepat
c
viru
instead
hcv
use
previous
commun
order
distinguish
hog
cholera
viru
human
cytomegaloviru
also
gener
abbrevi
hcv
abbrevi
hocv
suggest
hog
cholera
viru
present
review
highlight
main
aspect
hepcv
pathogenesi
molecular
properti
especi
relat
pestivirus
review
pestivirus
see
detail
inform
reader
refer
recent
review
choo
etal
bradley
et
al
choo
posttransfus
pt
hepat
still
rel
common
consequ
blood
transfus
studi
incid
usa
estim
applic
diagnost
test
hepat
b
viru
hbv
hepat
viru
hav
indic
pt
hepat
caus
virus
rather
anoth
viru
es
term
nanbh
viru
recent
estim
ptnanbh
present
observ
usa
europ
japan
caus
hepcv
amount
case
per
annum
usa
alon
addit
intraven
drug
addict
hemophiliac
high
risk
acquir
hepcv
infect
hepcv
also
implic
caus
sporad
case
nanbh
anoth
recent
discov
hepat
viru
hepat
e
viru
hev
caliciviruslik
viru
mainli
associ
enter
transmit
hepat
acut
infect
hepcv
seem
less
sever
caus
hbv
hav
greater
proport
hepcv
hbv
infect
like
progress
persist
chronic
state
estim
chronic
carrier
develop
cirrhosi
liver
furthermor
chronic
infect
hepcv
link
develop
hepatocellular
carcinoma
europ
japan
usa
see
definit
inform
present
avail
mechan
nonparenter
transmiss
hepcv
vector
altern
host
identifi
intrafamili
sexual
transmiss
implic
littl
also
present
known
pathogenesi
hepcv
attempt
infect
variou
cell
cultur
system
small
laboratori
anim
unsuccess
howev
hepcv
readili
transmit
parent
inject
chimpanze
serv
year
primari
model
system
nanbh
see
chimpanze
also
develop
hepat
inject
factor
viii
concentr
factor
ix
complex
implic
transmiss
nanbh
human
recipi
nanbh
serial
transmit
parent
inject
chimpanze
chimpanze
see
clinic
diseas
chimpanze
mimic
observ
human
may
vari
greatli
individu
human
chimpanze
infect
often
remain
asymptomat
acut
ill
develop
gener
occur
week
pi
consist
rang
symptom
includ
fever
chill
headach
weak
jaundic
parenter
nonparenter
transmiss
hepcv
infect
seem
mainli
local
liver
sinc
tissu
damag
seem
limit
tissu
liver
injuri
associ
characteris
alter
cytoplasm
infect
affect
hepatocyt
human
chimpanze
review
includ
dens
reticular
inclus
bodi
convolut
membran
deriv
prolifer
smooth
endoplasm
reticulum
bundl
granular
microtubul
characterist
tubular
structur
initi
earn
hepcv
name
tubuleform
agent
also
mani
endotheli
cell
found
contain
peculiar
bundl
hexagonalpack
microtubul
section
resembl
array
nm
particl
ultrastructur
chang
howev
uniqu
hepcv
infect
similar
chang
observ
cell
infect
rna
virus
review
may
repres
gener
respons
cell
cytotox
effect
virus
monoclon
antibodi
gener
specif
interact
tubular
aggreg
liver
biopsi
nanbh
hepat
delta
virusinfect
chimpanze
seem
like
ultrastructur
chang
antigen
format
mediat
interferon
form
cours
host
cellspecif
respons
infect
virus
mechan
liver
injuri
fulli
understood
factor
cytocid
replic
hepcv
hepatocyt
may
involv
liver
injuri
usual
associ
inflammatori
reaction
mark
increas
alanin
aminotransferas
alt
activ
circul
gener
featur
reflect
liver
injuri
elev
plasma
alt
activ
serv
gener
indic
liver
injuri
measur
blood
bank
surrog
assay
screen
blood
donor
potenti
infect
nanbh
virus
recent
develop
assay
antibodi
hepcv
polypeptid
c
part
viral
nonstructur
protein
see
allow
studi
humor
antibodi
respons
hepcvinfect
patient
chimpanze
recent
studi
store
blood
sampl
prospect
studi
usa
patient
transfusionassoci
chronic
hepat
document
liver
biopsi
indic
time
cours
chang
plasma
alt
activ
format
antihepcv
antibodi
vari
consider
patient
number
common
featur
howev
observ
agreement
earlier
studi
onset
acut
infect
gener
occur
week
transfus
associ
increas
plasma
alt
activ
fold
well
increas
serum
bilirubin
level
patient
develop
antic
hepcv
antibodi
averag
week
transfus
howev
high
antibodi
level
persist
one
patient
least
year
serum
alt
activ
level
vari
greatli
patient
cours
chronic
infect
signific
elev
alway
preval
similarli
donor
sera
test
contain
signific
antihepcv
antibodi
antihepcv
antibodi
posit
sera
exhibit
elev
alt
activ
anoth
prospect
studi
taiwan
chronic
ptnanbh
patient
develop
antic
hepcv
antibodi
week
transfus
compar
result
report
studi
usa
japan
itali
germani
greec
holland
summar
total
patient
chronic
ptnanbh
seroposit
hepcv
antibodi
preval
serum
antihepcv
antibodi
patient
sporad
nanbh
hemophiliac
intraven
drug
abus
slightli
lower
wherea
preval
among
blood
donor
normal
serum
alt
activ
rang
two
experiment
infect
chimpanze
antic
hepcv
antibodi
becam
detect
week
pi
respect
wherea
ultrastructur
chang
liver
becam
appar
first
week
pi
infectionrel
increas
serum
alt
activ
occur
week
pi
ultrastructur
abnormalti
liver
serum
antic
antibodi
persist
one
chimpanze
least
month
pi
disappear
one
serum
alt
activ
return
near
normal
overal
result
suggest
screen
donor
antihepcv
antibodi
could
prevent
major
case
ptnanbh
includ
mani
might
miss
assay
surrog
marker
long
latent
period
hepcv
infect
develop
antic
antibodi
human
chimpanze
week
howev
indic
consider
time
period
exist
hepcv
transmit
detect
immunolog
test
interest
question
whether
long
latent
period
may
reflect
late
antibodi
respons
nonstructur
protein
measur
antic
immun
assay
perhap
antibodi
structur
protein
hepcv
see
form
rapidli
inde
report
antibodi
hepcv
core
protein
detect
western
blot
higher
proport
sera
patient
chronic
nanbh
antibodi
c
antigen
anoth
recent
studi
sera
chronic
nanbh
patient
posit
antibodi
hepc
viru
core
protein
c
antigen
respect
furthermor
one
nanbh
pt
patient
anticor
protein
antibodi
becam
first
detect
serum
week
transfus
wherea
antibodi
c
antigen
first
detect
week
transfus
also
becom
appar
hepcv
rna
becom
detect
polymeras
chain
reaction
pcr
procedur
much
sooner
infect
antihepcv
antibodi
hepcv
rna
might
detect
absenc
detect
level
serum
antibodi
procedur
involv
centrifug
plasma
rpm
beckmann
ultracentrifug
h
extract
rna
pellet
materi
revers
transcript
rna
use
appropri
antisens
oligonucleotid
primer
hepcv
genom
sequenc
amplif
product
addit
appropri
sens
oligonucleotid
primer
pcr
product
detect
southern
blot
analysi
use
label
hepcv
cdna
lie
two
primer
use
desir
pcr
product
clone
sequenc
use
primer
publish
sequenc
see
hepcv
rna
detect
serum
two
experimentmli
infect
chimpanze
day
pi
also
detect
serum
one
patient
acut
pt
nanbh
seroneg
antic
antibodi
serum
one
chronic
infect
chimpanze
liver
sera
patient
chronic
nanbh
context
interest
patient
acut
resolv
hepcv
infect
develop
antic
antibodi
question
aris
factor
involv
resolut
infect
elimin
viru
perhap
latter
mediat
antibodi
viral
protein
repres
c
antigen
cellular
immun
respons
sinc
hepcv
titrat
assay
avail
present
expens
endpoint
dilut
assay
chimpanze
marmoset
see
limit
inform
avail
hepcv
viremia
infect
human
chimpanze
cours
diseas
nevertheless
data
indic
serum
hepcv
titer
gener
low
ie
chimpanze
infecti
dose
cid
ml
howev
titer
cidml
serum
observ
plasma
select
chimpanze
period
exacerb
chronic
phase
diseas
also
liver
tissu
one
anim
contain
cidg
tissu
unusu
titer
least
cidml
observ
serum
one
patient
acut
nanbh
strain
h
recent
studi
japan
patient
hepatocellular
carcinoma
lack
serum
antibodi
hbv
found
seroposit
hepcv
c
antigen
compar
incid
control
group
similar
incid
serum
antic
hepcv
antibodi
report
anoth
group
patient
hepatocellular
carcinoma
japan
although
similar
result
report
usa
europ
implic
chronic
hepcv
infect
caus
hepatocellular
carcinoma
potenti
mechan
effect
remain
elucid
sinc
virus
like
hepcv
lack
oncogen
replic
via
dna
intermedi
indirect
effect
indic
perhap
extens
stimul
hepatocyt
prolifer
cours
chronic
liver
injuri
play
role
recent
random
control
trial
indic
treatment
unit
recombin
interferon
intron
scheringplough
kenilworth
nj
thrice
weekli
effect
control
nanbh
mani
patient
decreas
serum
alt
activ
improv
histolog
featur
liver
observ
howev
interferon
treatment
seem
result
termin
infect
sinc
patient
relaps
treatment
discontinu
month
limit
inform
present
avail
structur
biochem
properti
hepcv
filtrat
studi
shown
diamet
infecti
virion
nm
nm
electron
microscop
examin
reveal
togaviruslik
particl
diamet
nm
sera
chimpanze
human
chronic
nanbh
similar
particl
observ
cytoplasm
cisterna
hepatocyt
infect
chimpanze
origin
ident
particl
ascertain
viruslik
particl
detect
electron
microscopi
exhibit
buoyant
densiti
sucros
densiti
gradient
contrast
buoyant
densiti
gcm
observ
sucros
densiti
gradient
centrifug
gradient
fraction
assay
infecti
hepcv
titrat
chimpanze
w
bradley
per
comm
sediment
analys
conclud
sediment
coeffici
hepcv
hepcv
envelop
viru
sinc
infect
destroy
extract
chloroform
infect
also
abolish
heat
sequenc
hepcv
rna
genom
determin
via
sequenc
cdna
initi
randomprim
express
cdna
librari
x
gttl
prepar
rna
extract
infecti
materi
concentr
larg
volum
high
titer
plasma
chimpanze
see
chronic
nanbh
infect
anim
repres
second
chimpanze
passag
viru
present
human
factor
viii
concentr
cdna
librari
screen
serum
chronic
nanbh
patient
potenti
sourc
antivir
antibodi
singl
posit
clone
see
fig
identifi
among
total
clone
use
clone
larger
overlap
cdna
clone
isol
clone
cdna
hybrid
human
chimpanze
cell
dna
southern
hybrid
analys
hybrid
rna
extract
liver
nanbh
viru
infect
chimpanze
northern
hybrid
analys
clone
cdna
hybrid
oligo
dt
select
rna
rang
result
indic
put
posit
strand
viral
rna
isol
infecti
plasma
size
least
kb
result
also
suggest
hepcv
rna
contain
poli
sequenc
unclear
whether
bind
dt
due
intern
poli
sequenc
see
three
addit
cdna
clone
isol
origin
cdna
librari
use
clone
cdna
probe
found
encod
continu
orf
reconstruct
clone
c
encod
orf
see
fig
fuse
human
superoxid
dismutas
sod
cdna
c
facilit
effici
express
foreign
protein
yeast
express
fusion
protein
contain
amino
acid
yeast
sodhepcv
polypeptid
produc
yeast
use
develop
radioimmun
assay
ria
elisa
assay
antihepcv
antibodi
commerci
elisa
kit
avail
ortho
diagnost
system
raritan
ny
abbott
diagnost
chicago
il
discuss
alreadi
assay
use
extens
alreadi
prospect
studi
screen
blood
donor
serum
antic
hepcv
antibodi
primer
extens
analys
sequenc
total
hepcv
genom
initi
determin
encod
continu
orf
amino
acid
sequenc
locat
toward
hepcv
genom
see
fig
exhibit
certain
similar
flavivirus
pestivirus
see
recent
sequenc
analys
presum
encod
structur
protein
well
origin
chimpanze
hepcv
isol
various
refer
prototyp
hepcv
hepcvpt
hepcvuc
complet
sequenc
total
nucleotid
report
genom
encod
continu
orf
amino
acid
tabl
translat
initi
codon
start
nucleotid
report
recent
consensu
sequenc
also
report
two
hepcv
genom
isol
pool
plasma
nine
japanes
nanbh
patient
refer
hepcvj
fifti
japanes
blood
donor
elev
plasma
alt
activ
refer
hepcvkb
studi
viru
particl
collect
plasma
ultracentrifug
rna
extract
pellet
materi
revers
transcrib
cdna
librari
prepar
k
gttl
one
studi
viral
rna
revers
transcrib
use
appropri
antisens
oligonucleotid
primer
viral
rna
polyadenyl
revers
transcrib
use
oligo
dt
primer
studi
viral
rna
revers
transcrib
use
random
hexanucleotid
primer
nucleotid
long
sequenc
hepcvj
rna
contain
untransl
segment
nucleotid
length
respect
tabl
genom
hepcvkb
nucleotid
long
possess
nucleotid
long
untransl
segment
tabl
segment
nucleotid
longer
report
hepcvj
kb
respect
may
repres
true
hepcv
genom
sinc
sever
independ
clone
termin
sequenc
yterminu
potenti
form
hairpin
structur
calcul
ag
valu
segment
resembl
pestivirus
rather
flavivirus
greater
length
presenc
short
orf
hepcv
segment
encod
three
orf
amino
acid
function
identifi
orf
addit
exhibit
consider
nucleotid
homolog
segment
pestiviru
genom
fact
four
block
nucleotid
show
sequenc
ident
whether
yend
genom
cap
unknown
segment
hepcvj
kb
rna
nucleotid
longer
report
contain
repeat
separ
au
well
termin
string
us
tabl
sequenc
probabl
repres
actual
viral
genom
sinc
sequenc
except
displac
one
c
report
hepcvkb
j
rna
see
tabl
howev
uncertainti
still
exist
concern
true
sinc
report
genom
sequenc
deriv
singl
cdna
result
may
suggest
genom
rna
hepcv
possess
tail
rather
poli
u
tail
conclus
correct
follow
complementari
neg
strand
possess
tail
interestingli
genom
rna
also
possess
arich
segment
orf
nucleotid
segment
hepcvj
kb
whether
arich
segment
function
hepcv
replic
unclear
present
nevertheless
could
account
weak
bind
posit
neg
strand
hepcv
rna
oligo
dt
observ
genom
rna
hand
han
et
al
suggest
least
hepcv
rna
molecul
may
polyadenyl
cdna
viral
genom
could
gener
revers
transcript
rna
extract
high
titer
plasma
infect
chimpanze
use
unrel
oligonucleotid
dt
tail
primer
amplif
product
pcr
yield
three
type
cdna
contain
poli
tail
one
cdna
encompass
nucleotid
segment
rna
plu
poli
tail
addit
sequenc
j
kb
genom
end
nucleotid
human
hepcv
isol
deriv
anoth
batch
plasma
healthi
japanes
carrier
determin
noncod
segment
nucleotid
follow
orf
amino
acid
overlap
amino
acidlong
sequenc
amino
acid
determin
six
differ
hepcv
isol
four
usa
two
itali
gene
product
hepcv
identifi
basi
amino
acid
sequenc
long
orf
variou
hepcv
isol
hydrophob
profil
predict
protein
locat
potenti
glycosyl
site
similar
properti
protein
encod
pestiviru
flaviviru
genom
certain
predict
made
first
amino
acid
ntermin
end
thought
repres
nucleocapsid
protein
c
fig
format
kda
p
protein
demonstr
mammalian
cell
transfect
cdna
sequenc
control
foreign
promot
transfect
bacteria
furthermor
put
nucleocapsid
protein
hepcv
exhibit
similar
high
content
basic
amino
acid
nucleocapsid
protein
flavivirus
pestivirus
lack
nglycosyl
site
next
amino
acid
hepcv
genom
thought
repres
envelop
glycoprotein
e
fig
potenti
protein
mostli
hydrophob
contain
six
possibl
nglycosyl
site
hydrophath
plot
domain
resembl
pestivirus
hepcv
genom
seem
encod
second
adjac
glycoprotein
amino
acid
length
seem
correspond
locat
major
structur
glycoprotein
pestivirus
gp
nonstructur
ns
glycoprotein
flavivirus
see
fig
two
predict
hepcv
glycoprotein
orf
preced
put
signal
peptid
sequenc
preliminari
studi
indic
hepcv
may
possess
least
three
structur
protein
kda
basic
nucleocapsid
protein
c
two
glycoprotein
hydrophob
kda
protein
e
glycoprotein
arrang
basic
resembl
pestivirus
rather
flavivirus
except
hepcv
genom
encod
protein
correspond
gp
pestivirus
therefor
shorter
review
pestivirus
see
anoth
interpret
report
hepcv
genom
sequenc
first
amino
acid
make
nucleocapsid
protein
next
approxim
amino
acid
repres
matrix
protein
e
singl
envelop
glycoprotein
hepcv
e
nonstructur
protein
genom
organ
would
equival
flavivirus
except
prem
segment
would
delet
question
interpret
correct
resolv
isol
character
structur
nonstructur
protein
viru
consider
similar
also
exist
hepcv
flavivirus
pestiviru
genom
locat
specif
motif
gener
associ
genom
positivestrand
rna
virus
see
fig
replicas
motif
character
consensu
gdd
sequenc
locat
close
hepcv
orf
compar
locat
ns
p
protein
flavivirus
pestivirus
respect
see
fig
serin
proteinas
motif
gxsgxp
found
hepcv
genom
rel
posit
genom
flavivirus
ns
pestivirus
p
see
fig
immedi
downstream
put
proteinas
sequenc
consensu
sequenc
genom
three
virus
typic
propos
superfamili
helicas
protein
hepcv
genom
also
encod
highli
hydrophob
protein
sequenc
equival
ns
flavivirus
amino
termin
end
p
pestivirus
respect
see
fig
overal
howev
amino
acid
sequenc
distantli
relat
flavivirus
pestivirus
differ
otherwis
great
similar
genom
organ
viron
properti
hepcv
suggest
classifi
new
genu
within
famili
flavivirida
yuntransl
segment
highli
conserv
exampl
upstream
continu
orf
kb
j
differ
one
two
nucleotid
similarli
maximum
diverg
nucleotid
observ
segment
isol
usa
australia
itali
japan
korea
argentina
south
africa
taiwan
high
degre
conserv
suggest
provid
import
regulatori
function
segment
seem
somewhat
less
conserv
although
one
nucleotid
differ
segment
hepcvkb
j
nucleotid
tsegment
differ
japanes
isol
least
consider
sequenc
differ
also
exist
variou
hepcv
isol
long
orf
part
vari
equal
exampl
orf
two
japanes
isol
hepcvkb
j
exhibit
amino
acid
ident
amino
acid
ident
chimpanze
isol
hepcvkb
hepcvj
respect
sequenc
analyz
use
molecular
biolog
inform
resourc
suit
program
mbir
baylor
colleg
medicin
houston
tx
multipl
align
produc
implement
klotz
blanten
method
protein
sequenc
analyz
use
homolog
dayhoff
score
matrix
howev
even
though
overal
percentag
amino
acid
differ
two
japanes
isol
consider
number
differ
amino
acid
latter
involv
indic
rather
complex
relationship
report
genom
sequenc
amino
acid
differ
three
strain
particularli
preval
segment
encompass
amino
acid
segment
repres
e
amino
termin
portion
adjac
downstream
protein
see
fig
seem
contain
area
higher
averag
variabl
see
segment
amino
acid
diverg
amount
hepcvkb
j
kb
j
respect
contrast
replicas
domain
amino
acid
hepcvkb
j
differ
two
amino
acid
see
fig
overal
nucleotid
sequenc
homolog
code
segment
hepcvkb
j
j
kb
addit
specif
sequenc
variou
hepcv
isol
amplifi
pcr
clone
sequenc
put
nucleocapsid
protein
sequenc
deriv
pcr
product
rna
extract
healthi
japanes
carrier
plasma
exhibit
amino
acid
ident
sequenc
determin
origin
chimpanze
hepcv
isol
ident
nucleotid
level
furthermor
amino
acid
nucleotid
ident
observ
nucleotid
sequenc
encod
part
put
envelop
protein
fig
two
hepcv
isol
compar
nucleotid
amino
acid
sequenc
four
hepcv
isol
usa
two
itali
amino
acid
moder
variabl
domain
approxim
amino
acid
e
region
hypervari
domain
region
v
approxim
amino
acid
junction
e
e
see
fig
identifi
although
overal
diverg
six
isol
nucleotid
amino
acid
hypervari
region
account
observ
amino
acid
differ
isol
signific
appar
variabl
glycoprotein
code
sequenc
unclear
could
consequ
immun
select
need
consid
futur
develop
hepcv
vaccin
consider
differ
also
report
nonstructur
protein
sequenc
variou
hepcv
isol
studi
other
cdna
clone
bp
gener
pcr
rna
extract
japanes
patient
chronic
n
n
b
h
exhibit
nucleotid
ident
resembl
differ
kbj
furthermor
hepcv
r
n
extract
patient
detectahl
pcr
use
certain
primer
base
sequenc
c
n
clone
nonstructur
region
gener
pcr
rna
extract
japanes
blood
donor
howev
exhibit
less
diverg
prototyp
sequenc
select
genom
segment
cdnapcr
method
shown
predict
amino
acid
sequenc
japanes
hepcv
isol
diverg
hepcvj
japanes
isol
homolog
hepcvj
combin
result
indic
numer
variant
hepcv
present
variou
part
world
variant
hepcvj
might
repres
subtyp
work
requir
establish
preval
variou
variant
differ
countri
sinc
amino
acid
sequenc
diverg
preval
put
envelop
glycoprotein
segment
equival
amino
terminu
p
pestivirus
ns
flavivirus
anoth
interest
question
whether
variant
becom
select
cours
chronic
infect
due
immunolog
pressur
